Showing 1 - 12 results of 12 for search 'Yu. M. Pozdnyakov', query time: 0.02s Refine Results
  1. 1
    Functional heart diseases – new realities

    Functional heart diseases – new realities by Yu. M. Pozdnyakov, V. S. Volkov

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE AND PERIPHERAL ARTERY DISEASE, RECEIVING LONG-TERM MILDRONATE THERAPY

    EXERCISE CAPACITY IN PATIENTS WITH CORONARY HEART DISEASE AND PERIPHERAL ARTERY DISEASE, RECEIVING LONG-TERM MILDRONATE THERAPY by V. Ya. Dzerve, Yu. M. Pozdnyakov

    Published 2011-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Transoesophageal electrocardiography features in patients with atrioventricular nodal reentrant tachycardia

    Transoesophageal electrocardiography features in patients with atrioventricular nodal reentrant tachycardia by A. V. Tarasov, K. V. Davtyan, Yu. M. Pozdnyakov

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Risk factor structure and relative prevalence of pathological alterations in arterial hypertension patients of various age groups

    Risk factor structure and relative prevalence of pathological alterations in arterial hypertension patients of various age groups by A. M. Urinsky, R. L. Kuznetsov, Yu. M. Pozdnyakov, S. A. Boytsov

    Published 2006-08-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem

    Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem by Yu. M. Pozdnyakov, O. N. Miller, S. A. Luchinsky, V. L. Doshchitsyn

    Published 1970-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives

    Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives by V. P. Mikhin, Yu. M. Pozdnyakov, F. E. Khlebodarov, O. N. Koltsova

    Published 2012-02-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE

    CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE by A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Workplace programme of cardiovascular prevention: clinical effectiveness

    Workplace programme of cardiovascular prevention: clinical effectiveness by A. M. Kalinina, A. V. Kontsevaya, S. V. Belonosova, R. A. Eganyan, Yu. M. Pozdnyakov, N. V. Kiseleva

    Published 2010-06-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Health-related quality of life, psychological status, and cardiovascular risk factors in intellectual workers

    Health-related quality of life, psychological status, and cardiovascular risk factors in intellectual workers by A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, Yu. M. Pozdnyakov, T. S. Romanenko, M. G. Omelyanenko, R. A. Eganyan

    Published 2009-08-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION

    EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HE... by O. N. Miller, S. A. Starichkov, Yu. M. Pozdnyakov, S. A. Luchinsky, A. V. Tarasov, V. L. Doshchitsyn, O. A. Kramynina, E. G. Volkova, D. L. Ilyinykh

    Published 2010-08-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey

    Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey by N. V. Pogosova, R. G. Oganov, S. A. Boytsov, A. K. Ausheva, O. Yu. Sokolova, A. A. Kursakov, I. V. Osipova, O. N. Antropova, Yu. M. Pozdnyakov, A. O. Salbieva, I. N. Lelchuk, T. A. Gusarova, N. V. Gomyranova, N. A. Skazin, K. Kotseva

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    PSYCHOSOCIAL FACTORS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS: RESULTS OF THE RUSSIAN PART OF INTERNATIONAL MULTICENTER STUDY EUROASPIRE IV

    PSYCHOSOCIAL FACTORS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS: RESULTS OF THE RUSSIAN PART OF INTERNATIONAL MULTICENTER STUDY EUROASPIRE IV by N. V. Pogosova, R. G. Oganov, S. A. Boytsov, A. K. Ausheva, O. Yu. Sokolova, A. A. Kursakov, Yu. M. Pozdnyakov, A. O. Salbieva, I. N. Lelchuk, T. A. Gusarova, N. V. Gomyranova, A. V. Karpova, N. A. Eliseeva, E. B. Akhmedova, K. K. Bedeynikova, M. N. Korneeva

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: